Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding shares is at $39.3 million.
- Aptorum Group (NASDAQ:APM) shares rose 13.86% to $1.56. The company's market cap stands at $55.5 million.
- HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 13.29% to $1.79. The market value of their outstanding shares is at $97.8 million. The company's, Q4 earnings came out today.
- NeuBase Therapeutics (NASDAQ:NBSE) shares increased by 12.69% to $2.22. The company's market cap stands at $72.7 million.
- Lucid Diagnostics (NASDAQ:LUCD) stock increased by 11.88% to $3.39. The market value of their outstanding shares is at $124.7 million.
- MorphoSys (NASDAQ:MOR) stock rose 9.46% to $7.17. The company's market cap stands at $979.3 million.
Losers
- Hyperfine (NASDAQ:HYPR) shares declined by 8.8% to $3.22 during Thursday's pre-market session. The company's market cap stands at $225.5 million. The company's, Q4 earnings came out yesterday.
- Impel NeuroPharma (NASDAQ:IMPL) shares decreased by 8.11% to $7.37. The company's market cap stands at $169.8 million. As per the press release, Q4 earnings came out today.
- Immutep (NASDAQ:IMMP) shares declined by 7.9% to $3.15. The market value of their outstanding shares is at $269.0 million.
- GBS (NASDAQ:GBS) stock decreased by 7.59% to $0.89. The market value of their outstanding shares is at $13.2 million.
- Neogen (NASDAQ:NEOG) shares decreased by 7.53% to $31.2. The company's market cap stands at $3.3 billion. As per the news, the Q3 earnings report came out today.
- Diffusion Pharmaceuticals (NASDAQ:DFFN) shares declined by 7.38% to $0.31. The market value of their outstanding shares is at $32.0 million. As per the press release, Q4 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.